Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nephros (NEPH) Long-Term Debt Issuances (2018)

Nephros has reported Long-Term Debt Issuances over the past 3 years, most recently at $1.2 million for Q1 2018.

Quarterly results put Long-Term Debt Issuances at $1.2 million for Q1 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $1.2 million (changed N/A YoY), and the annual figure for FY2020 was $479000.0, changed.
Long-Term Debt Issuances for Q1 2018 was $1.2 million at Nephros, up from -$38000.0 in the prior quarter.
Over the last five years, Long-Term Debt Issuances for NEPH hit a ceiling of $1.6 million in Q3 2014 and a floor of -$38000.0 in Q4 2014.